1. Home
  2. IMCR vs TNC Comparison

IMCR vs TNC Comparison

Compare IMCR & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.37

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$76.88

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMCR
TNC
Founded
2008
1870
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.3B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMCR
TNC
Price
$36.37
$76.88
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$67.00
$113.50
AVG Volume (30 Days)
338.1K
117.6K
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
1.61%
EPS Growth
N/A
N/A
EPS
N/A
2.91
Revenue
$379,590,000.00
$1,240,800,000.00
Revenue This Year
$32.31
N/A
Revenue Next Year
$10.50
$5.63
P/E Ratio
N/A
$26.46
Revenue Growth
28.11
N/A
52 Week Low
$23.15
$67.32
52 Week High
$40.72
$90.44

Technical Indicators

Market Signals
Indicator
IMCR
TNC
Relative Strength Index (RSI) 47.15 58.58
Support Level $35.35 $76.22
Resistance Level $38.40 $78.25
Average True Range (ATR) 1.89 1.69
MACD -0.45 0.72
Stochastic Oscillator 13.33 82.53

Price Performance

Historical Comparison
IMCR
TNC

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

Share on Social Networks: